2019 Replays

Bernard Charles, Vice Chairman of the Board of Directors and Chief Executive Officer, demonstrates that Dassault Systemes is a scientific company, that a science-based platform enabling virtual discovery is an essential ingredient to sustainable innovation, and that today's industry renaissance requires a collaborative, open approach to solve key societal challenges such as improving human lives, developing a sustainable world, and accelerating product innovation.

Ameet Nathwani, Chief Medical Officer and Chief Digital Officer at Sanofi, defines digital health as the convergence of biological, engineering and physical sciences to enhance and personalize healthcare. Digital health is disruptive. Powered by a science-based approach, artificial intelligence, health apps, and virtual health care are all poised to help bring innovative health products and solutions to market faster, safer, and more conviently than ever.

Moderated discussion by Life Sciences innovators covering 3D bioprinting, precision medicine, personalized patient continuous care, and innovative therapies in neuroscience. Topics include managing and mining data, patient-specific bioengineering, and latest advancements and outcomes when science and technology are leveraged.

Neil Gershenfeld, Director of MIT Center for Bits and Atoms, is an original and very broad thinker.With statements like, "Computer Science is one of the worst things to happen to computers or to science," Gershenfeld shows that the division between the digital and real realms is artificial and that wonderful things happen when the distance between the virtual and real is brought to zero.

Highlighted by neural networks, fab labs, Lass' Law, and artificial evolution, this presentation comes full circle to show that sustainable innovation and crowd-sourced creativity accessible by all are the keys to address today's challenges.

Leaders from different industries discuss trends in product innovation including consumer-specific customization, the role of new technology in developing the workforce of the future, and how this technology is transforming the aerospace industry.

Topics will include virtual discovery and testing to speed product development, 3D printing as a means to provide mass customization in the shoe industry, and the role of collaborative technology and virtual discovery to disrupt the aerospace industry and accelerate the development of personal air vehicles for urban mobility.

Genevieve Berger, Chief Research Officer at Firmenich, shows that scent and taste - representative of two of our senses that are often ignored - are central to increased quality, safety, and sense of value in people's lives and in the products they consume.

These qualities can be scientifically measured, developed, designed, tracked, modified, and optimized in the same way that discrete hard industrial products can be. Dr. Berger demonstrates that an open multidisciplinary approach provides the right scientific basis for Ferminich's sustainability goal and that sustainability is a business adding value and security to the consumer products industry today.

In this keynote Dr. Michio Kaku offers a stunning and provocative vision of the future. Based on interviews with over 300 of the world’s top scientists, Dr. Kaku presents the revolutionary developments in medicine, computers, energy, quantum physics, and space travel that will change our lives and alter the course of civilization itself.

Insightful discussion on sustainable innovation covering material production, product lightweighting, and government certification for emissions reduction. Topics include sustainable mining practices to provide the raw materials needed to transform to a sustainable society, workforce training, and efficiency considerations for applications of new materials including lightweighting, and the role of virtual discovery in achieving regulatory certification for next-gen over-the-road truck/trailer designs.

Marcel Wubbolts, Chief Technology Officer at Corbion, discusses the need to reconsider industrial processes to include carbon emissions.Once understood, many processes can be re-engineered to minimize or eliminate carbon emissions. Corbion's industrial scale manufacturing process for lactic acid polymer is described. Corbion is transforming the process to become carbon negative (a carbon absorber) providing a sustainable feedstock for future bio-degradable plastics based on polylactic acid.

Jennifer Wilcox, Professor of Chemical Engineering at Worcester Polytechnic Institute, shows that direct carbon capture will be an essential part of responding to and mitigating our changing climate.Carbon capture technology is already here today and will become more cost and energy efficient to meet the coming demand. Captured carbon will serve as a valuable economic raw material and feedstock to provide the needed incentive to accelerate and scale the technology.

Glen De Vries, President and Co-founder of Medidata, provides his views on the importance of big data to provide missing insight and provide hidden value for product development, therapeutics, and personalized medicine in today's clinical trial development and execution landscape.

Society is at the threshold of a new age when machines will no longer be separate, lifeless mechanisms, but will instead be intimate extensions of the human body. Such a merging of body and machine will not only improve the quality of life for disabled people, but will allow persons with normal physiologies to experience augmented capabilities – cognitively, emotionally and physically. There soon will be a world where technology will merge with our bodies to forever change our concept of human capability.

Hugh Herr features research work from MIT’s Center for Extreme Bionics that is blurring the distinction between “able-bodied” and “disabled,” demonstrating technologies at the neural-digital interface. These new research initiatives are capable of addressing a plethora of conditions currently at clinical impasses, from optogenetic approaches to treat blindness to the development of smart prostheses that can emulate – and even exceed the capabilities of biological limbs. Herr believes that through an ever-increasing technological sophistication, human disability will largely be eliminated in this 21st century, setting the stage for innovations that will ultimately benefit all humanity.

Lisa Randall, Physics Professor at Harvard University, discusses the challenges we humans face in imagining scales very different from our own and shows how various fields of science have tackled some of those challenges through extremely careful measurements and through simulations--often in tandem. She discusses some practical applications of such research.